Do all aromatase inhibitors have similar efficacy and safety?

Future Oncol. 2017 Aug;13(19):1673-1676. doi: 10.2217/fon-2017-0228. Epub 2017 Aug 23.

Authors

Mehmet An Şendur¹, Burak Bilgin¹, Mutlu Hızal¹, Nuriye Yıldırım Özdemir¹, Muhammed Bülent Akıncı¹, Didem Şener Dede¹, Bulent Yalçın¹

Affiliation

¹ Department of Medical Oncology, Faculty of Medicine, Yıldırım Beyazıt University, Bilkent, Ankara 06800, Turkey.

PMID: 28831832
DOI: 10.2217/fon-2017-0228

No abstract available

Keywords: aromatase inhibitors; breast cancer; endocrine treatment.

Publication types

Letter

MeSH terms

Antineoplastic Agents, Hormonal / administration & dosage
Antineoplastic Agents, Hormonal / adverse effects
Antineoplastic Agents, Hormonal / therapeutic use*
Aromatase Inhibitors / administration & dosage
Aromatase Inhibitors / adverse effects
Aromatase Inhibitors / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / mortality
Breast Neoplasms / pathology
Clinical Trials as Topic
Female
Humans
Treatment Outcome

Substances

Antineoplastic Agents, Hormonal
Aromatase Inhibitors